Literature DB >> 1483859

Acute monophasic focal demyelinating diseases of the central nervous system: longitudinal clinico-neuroradiological study of two patients.

P Di Bella1, F Logullo, M Danni, F Angeleri, L Chiaramoni, M Maricotti, N Foschi, U Salvolini.   

Abstract

We report the clinical features and laboratory-instrumental findings in two patients with acute monophasic demyelinating disease with focal clinical expression: one case of incomplete cervical transverse myelitis and one of focal supratentorial encephalitis. We describe the clinical course and evolution of the neuroradiological findings (CT and MRI) and discuss their pathological meaning and diagnostic value.

Entities:  

Mesh：

Year:  1992        PMID： 1483859     DOI： 10.1007/bf02229162

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN： 0392-0461


  10 in total

1.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications.

Authors:  A G Kermode; A J Thompson; P Tofts; D G MacManus; B E Kendall; D P Kingsley; I F Moseley; P Rudge; W I McDonald
Journal:  Brain       Date:  1990-10       Impact factor: 13.501

2.  Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis.

Authors:  J Kesselring; D H Miller; S A Robb; B E Kendall; I F Moseley; D Kingsley; E P du Boulay; W I McDonald
Journal:  Brain       Date:  1990-04       Impact factor: 13.501

Review 3.  Pathogenesis of multiple sclerosis. A critical reappraisal.

Authors:  C M Poser
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

Review 4.  Taxonomy and diagnostic parameters in multiple sclerosis.

Authors:  C M Poser
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

5.  Magnetic resonance imaging in asymptomatic disseminated vasculomyelinopathy.

Authors:  C M Poser
Journal:  J Neurol Sci       Date:  1989-12       Impact factor: 3.181

6.  Multifocal CT enhancement in MS.

Authors:  G C Ebers; F V Vinuela; T Feasby; B Bass
Journal:  Neurology       Date:  1984-03       Impact factor: 9.910

7.  Acute transverse myelitis: incidence and etiologic considerations.

Authors:  M Berman; S Feldman; M Alter; N Zilber; E Kahana
Journal:  Neurology       Date:  1981-08       Impact factor: 9.910

8.  High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.

Authors:  L Durelli; D Cocito; A Riccio; C Barile; B Bergamasco; G F Baggio; F Perla; M Delsedime; G Gusmaroli; L Bergamini
Journal:  Neurology       Date:  1986-02       Impact factor: 9.910

9.  Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography.

Authors:  C Pozzilli; S Bernardi; L Mansi; P Picozzi; F Iannotti; B Alfano; L Bozzao; G L Lenzi; M Salvatore; P Conforti
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-08       Impact factor: 10.154

10.  Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.

Authors:  D H Miller; P Rudge; G Johnson; B E Kendall; D G Macmanus; I F Moseley; D Barnes; W I McDonald
Journal:  Brain       Date:  1988-08       Impact factor: 13.501
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.